Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Open-market buy 10% owner bought 4,686 shares at $5.10 ($23,899)
  4. EFFECT Other Notice of Effectiveness
  5. 424B3 Offering Prospectus
  6. S-4/A Deal Registration Statement - Business Combination
  7. S-4/A Deal Registration Statement - Business Combination
  8. 8-K Event Executive or director change
  9. 4 Open-market buy 10% owner bought 10,851 shares at an average $4.95 ($53,691)
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. S-4/A Deal Registration Statement - Business Combination
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 8-K Event Other events
  14. 8-K Event Material agreement
  15. S-4 Deal Registration Statement - Business Combination
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 1 of 20 · 400 filings